NanoViricides
NNVC
#10572
Rank
NZ$57.78 M
Marketcap
NZ$2.26
Share price
1.22%
Change (1 day)
-11.96%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: NZ$57.78 Million

As of November 2026 NanoViricides has a market cap of NZ$57.78 Million. This makes NanoViricides the world's 10572th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$57.78 M30.39%
2025NZ$44.31 M16.14%
2024NZ$38.15 M101.42%
2023NZ$18.94 M-6.66%
2022NZ$20.29 M-67.66%
2021NZ$62.76 M47.96%
2020NZ$42.42 M194.07%
2019NZ$14.42 M-30.39%
2018NZ$20.72 M-73.6%
2017NZ$78.48 M-12.7%
2016NZ$89.9 M-9.82%
2015NZ$99.69 M-49.23%
2014NZ$0.19 B-32.82%
2013NZ$0.29 B221.37%
2012NZ$90.95 M-22.08%
2011NZ$0.11 B-55.86%
2010NZ$0.26 B71.31%
2009NZ$0.15 B-9.87%
2008NZ$0.17 B182.32%
2007NZ$60.66 M

End of Day market cap according to different sources

On Nov 15th, 2026 the market cap of NanoViricides was reported to be:

NZ$57.32 Million
by Nasdaq info icon info icon
NZ$57.09 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
NZ$382.08 B 661,094.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$656.81 B 1,136,515.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$235.30 B 407,089.41%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$185.07 B 320,176.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ$2.44 B 4,129.46%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$3.52 B 6,001.40%๐Ÿ‡บ๐Ÿ‡ธ USA